agilon health, inc. (NYSE:AGL) Given Average Recommendation of “Hold” by Brokerages

agilon health, inc. (NYSE:AGL) has earned a consensus recommendation of “Hold” from the twenty analysts that are presently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, fourteen have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $8.03.

AGL has been the subject of a number of analyst reports. Bank of America lowered agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a research report on Wednesday, October 2nd. Benchmark restated a “buy” rating and set a $9.00 price objective on shares of agilon health in a research report on Thursday, August 8th. Royal Bank of Canada restated an “outperform” rating and set a $8.00 price objective on shares of agilon health in a research report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft reduced their price objective on agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Finally, Evercore ISI cut their target price on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research note on Tuesday.

Insider Transactions at agilon health

In related news, CEO Steven Sell bought 20,000 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were bought at an average cost of $3.36 per share, with a total value of $67,200.00. Following the completion of the transaction, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 3.20% of the stock is owned by insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Vanguard Group Inc. raised its position in agilon health by 1.3% during the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock valued at $176,582,000 after buying an additional 371,537 shares during the period. AQR Capital Management LLC boosted its stake in agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after purchasing an additional 1,316,990 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in agilon health by 46.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,139,886 shares of the company’s stock valued at $127,256,000 after purchasing an additional 3,195,087 shares during the period. Susquehanna Fundamental Investments LLC lifted its position in shares of agilon health by 65.0% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after acquiring an additional 316,856 shares during the period. Finally, Capital International Investors lifted its position in shares of agilon health by 84.7% in the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after acquiring an additional 9,263,296 shares during the period.

agilon health Price Performance

Shares of AGL opened at $3.32 on Friday. The firm has a market cap of $1.37 billion, a price-to-earnings ratio of -4.74 and a beta of 0.54. The stock has a 50 day moving average of $4.19 and a 200-day moving average of $5.32. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.04. agilon health has a 52 week low of $2.99 and a 52 week high of $20.37.

agilon health (NYSE:AGL) last issued its earnings results on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). The company had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.56 billion. agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The business’s revenue was up 38.7% on a year-over-year basis. During the same quarter last year, the firm earned ($0.04) EPS. As a group, analysts forecast that agilon health will post -0.32 EPS for the current year.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.